← FDA Drug Approvals (Drugs@FDA)

ELREXFIO

BLA · Biologics License Application · Sponsor: PFIZER INC · Approved 2023-08-14

Drug application

FDA Application #

BLA761345

Application type

Biologics License Application

Brand name

ELREXFIO

Generic name

ELRANATAMAB-BCMM

Active ingredients

ELRANATAMAB

Dosage form

SOLUTION

Route

INJECTION

Marketing status

Prescription

Sponsor

PFIZER INC

Manufacturer

Pfizer Laboratories Div Pfizer Inc

First approval

2023-08-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown